Cellectis SA (CLLS) – cena akcií a novinky

DomovCLLS • NASDAQ

Cellectis SA

4,11 $

21. 1., 10:22:58 GMT-5 · USD · NASDAQ · Vylúčenie

AkcieKrajina cenného papiera: USA

Predch. zatv. cena

4,15 $

Denný rozsah

4,09 $ - 4,15 $

Rozsah rokov

1,10 $ - 5,48 $

Trhová kapitalizácia

291,23 mil. USD

Priemerný objem

91,93 tis.

Cena/zisk

Dividendový výnos

Novinky na trhu

Bitcoin.com News

pred 8 hodinami

Canaan dostáva upozornenie na nedostatok od Nasdaq po poklese akcií pod $1.00

Honeywell International (NASDAQ:HON) Price Target Raised to $250.00 at Argus

Investing News Network

pred 20 minútami

NYSE Content Advisory: Pre-Market Update + AI, Robotics, Autonomy In Focus at the World Economic Forum

hngnews.com

pred 40 minútami

US stocks steady a day after their biggest drop since October

Barron's

pred 6 hodinami

Dollar Under Pressure as Trump Touts U.S. Economy

Reuters

pred 48 minútami

Wall Street opens higher after rout, Trump speech in focus

Informácie

Cellectis is a French biopharmaceutical company. It develops genome-edited chimeric antigen receptor T-cell technologies for cancer immunotherapy. It has offices in Paris, New York City, and Raleigh, North Carolina. Wikipedia

Generálny riaditeľ

André Choulika

Dátum založenia

1999

Web

cellectis.com

Zamestnanci

219